Product and technology leadership
Product definition, technical strategy, development partners, design controls, manufacturing readiness, risks and technical board reporting.
Fractional medtech leadership
Senior leadership without a full-time appointment.
Genvissa provides continuing CTO, CSO, COO and programme leadership for medtech companies that need judgement, continuity and executive accountability, not occasional advice.
When advice is not enough
Some decisions need an accountable owner.
A strategy only creates value when someone connects the work, carries the decisions and keeps the programme controlled.
Early and scaling medtech companies often need senior leadership before they can justify, attract or fully utilise a permanent executive hire. The gap can leave founders coordinating specialists, suppliers and critical decisions without enough time or cross-functional experience.
A fractional remit provides continuing leadership around a defined outcome, while remaining proportionate to company stage, budget and internal capability.
Possible remits
Leadership shaped around the real gap.
Scientific and evidence leadership
Claims, evidence strategy, analytical and clinical priorities, external experts, study decisions and scientific communication.
Operational leadership
Operating model, governance, suppliers, quality interfaces, budgets, milestones, organisational priorities and execution controls.
Critical-path leadership
Cross-functional ownership of a major milestone, recovery programme, transfer, clinical-readiness phase or route-to-market initiative.
Decision and investor support
Clear board reporting, risk escalation, investment narrative, technical diligence support and alignment between capital and value inflections.
Build and hand over
Create the strategy, controls, team capability and operating rhythm, then support recruitment and a controlled transition to permanent leadership.
Mandate and authority
Agree the outcome, decisions, boundaries, reporting line, time commitment, internal interfaces and matters reserved for the board.
Roadmap and governance
Set priorities, milestones, risks, decision gates, partner responsibilities, budget logic and a proportionate reporting rhythm.
Hands-on leadership
Lead the work, coordinate specialists, challenge assumptions, make decisions within the mandate and keep accountability visible.
Capability and handover
Strengthen internal ownership, recruit or develop the right team and transfer knowledge, controls and unresolved actions clearly.
Good fit
Use fractional leadership for a defined need, not as a vague extra pair of hands.
Which companies benefit most?
Founder-led, funded and scaling medtech companies facing a meaningful product, evidence, operational or market milestone without the required senior capacity in place.
How much support is required?
The commitment is matched to the mandate. It may be a regular weekly rhythm, a time-bounded milestone or a recovery phase requiring more concentrated involvement.
Is the intention to become permanent?
Not necessarily. The remit may continue, reduce or transition to a permanent hire when the company has the stage, funding and clarity to make that appointment well.
Accountable senior capacity
Put clear ownership around the next value inflection.
Tell us what needs to be led, why it matters and where the current leadership gap sits.